Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Boundless Bio Inc
(NQ:
BOLD
)
3.400
-0.220 (-6.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boundless Bio Inc
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
August 12, 2024
BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Boundless Bio
Via
Business Wire
BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024
May 13, 2024
Boundless Bio just reported results for the first quarter of 2024.
Via
InvestorPlace
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 13, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
May 06, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 11, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
April 08, 2024
From
Boundless Bio
Via
Business Wire
Bayer-Backed Boundless Bio Falls After IPO
March 31, 2024
Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.